Δημοσίευση

Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia.

ΤίτλοςEffects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia.
Publication TypeJournal Article
Year of Publication2013
AuthorsKanaki, A. I., Sarafidis P. A., Georgianos P. I., Kanavos K., Tziolas I. M., Zebekakis P. E., & Lasaridis A. N.
JournalAm J Hypertens
Volume26
Issue5
Pagination608-16
Date Published2013 May
ISSN1941-7225
Λέξεις κλειδιάAged, Anticholesteremic Agents, Aorta, Blood Pressure, Comorbidity, Dose-Response Relationship, Drug, Double-Blind Method, Female, Hemodynamics, Heptanoic Acids, Humans, Hypercholesterolemia, Hypertension, Male, Middle Aged, Pulse Wave Analysis, Pyrroles, Treatment Outcome, Vascular Stiffness
Abstract

BACKGROUND: Experimental and clinical data suggest that statins exert anti-inflammatory and antiproliferative actions on vasculature beyond their lipid-lowering properties. Whether these pleiotropic effects of statins translate into a beneficial effect on arterial stiffness is not clear. This study aimed to evaluate the potential effects of low-dose atorvastatin treatment on arterial stiffness and central arterial pressure waveforms in patients with mild hypertension and hypercholesterolemia.METHODS: In a double-blind, randomized, placebo-controlled fashion, 50 hypertensive and hypercholesterolemic patients were allocated to receive 10 mg of atorvastatin or placebo for 26 weeks. Arterial stiffness was assessed by aortic pulse-wave velocity (PWV) using a Sphygmocor device. Central arterial pressure waveform parameters were estimated by radial artery applanation tonometry. Heart rate-adjusted augmentation index (AIx(75)) was used as measure of wave reflections.RESULTS: At study end, aortic PWV (9.0 ± 1.5 vs. 10.9 ± 2.6 m/sec; P < 0.001) and AIx(75) (24.9% ± 9.7% vs 28.8% ± 11.8%; P < 0.001) were significantly lower in the atorvastatin group than that placebo group. Furthermore, decreases in central aortic systolic blood pressure and pulse pressure were evident at study-end with atorvastatin but not with placebo (130 ± 8 vs. 138 ± 6 mm Hg, P < 0.001; 48 ± 7 vs. 53 ± 6 mm Hg, P < 0.05, respectively). Atorvastatin-induced reductions in aortic PWV during follow-up showed significant associations with changes in AIx(75) and central aortic systolic blood pressure and pulse pressure.CONCLUSIONS: This study shows that low-dose atorvastatin treatment improves arterial stiffness and exerts a reduction on central aortic pressures. These effects may represent a potential mechanism of cardiovascular risk reduction observed with statin use.CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov Database Identifier Number: NCT01126684.

DOI10.1093/ajh/hps098
Alternate JournalAm. J. Hypertens.
PubMed ID23449607

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.